MUFG Americas’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

MUFG Americas’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-452	Closed	-$1K	–	1034
2017 Q4	$1K	Buy	+452	New	+$938	﹤0.01%	1033
2016 Q2	–	Sell	-325	Closed	-$2K	–	1209
2016 Q1	$2K	Buy	+325	New	+$1.99K	﹤0.01%	1117
2015 Q4	–	Sell	-290	Closed	-$2K	–	1229
2015 Q3	$2K	Buy	290 +25	+9%	+$231	﹤0.01%	1121
2015 Q2	$3K	Buy	+265	New	+$3.4K	﹤0.01%	1051
2013 Q3	–	Sell	-4,000	Closed	-$65K	–	1502
2013 Q2	$65K	Buy	+4,000	New	+$124K	﹤0.01%	1110

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

MUFG Americas's INFI Position: Q1 2018 in Review

MUFG Americas sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2018, closing a stake of 452 shares — an estimated $1K sold.

MUFG Americas first reported a position in INFI in Q2 2013 and held it in 5 quarters. The position peaked at $65K in Q2 2013. 66 funds tracked by Wall St. Rank hold INFI as of Q1 2018.

MUFG Americas reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
MUFG Americas sold 452 Infinity Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1K.
MUFG Americas first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 5 quarters.
MUFG Americas's Infinity Pharmaceuticals, Inc. position peaked at $65K in Q2 2013.
66 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2018.

Based on MUFG Americas's 13F filing for Q1 2018, filed 7 May 2018.